Thus, we believe that tumor-specific CD4+ T cells can facilitate direct anti-tumor activity, which can be supported by TRAIL+ macrophages inducing the classical macrophage activation pathway that contributes to inhibition of tumor cell growth [65]. The gene discussed is CD4; the disease is neoplasm.